DR. DE PAUW, Algemene Geneeskunde SRL

1.7 FTE

DR. DE PAUW, Algemene Geneeskunde reported total assets of €1.86m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Sep 2026), with 1.7 full-time equivalent.

By total assets for 2025, DR. DE PAUW, Algemene Geneeskunde ranks among the 500 largest of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0882.029.116 · VAT BE0882029116
9320 Aalst
active in General medical practice activities (NACE 86210)
operating since 23 Jun 2006 (≈ 20 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of DR. DE PAUW, Algemene Geneeskunde shows with a free account.

See the score
Profile
SRL Micro · 1.7 FTE since 2006
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result114,491 €
Equity415,981 €
Cash26,125 €
EBITDA325,404 €
Total assets€1.86m
Headcount (avg FTE)1.7
The line marks its sector median: 72.4% (5478 companies).

Change 2022 → 2025: Equity +95 % Total assets -23 % Headcount (avg FTE) +70 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

DR. DE PAUW, Algemene Geneeskunde's annual accounts

20252024202320222021
Net result114,491 €
Equity415,981 €
Cash26,125 €
EBITDA325,404 €
Total assets€1.86m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 23 Sep 2026
  • Year ended 31 Dec 2024filed on 24 Sep 2025
  • Year ended 31 Dec 2023filed on 30 Aug 2024
  • Year ended 31 Dec 2022filed on 10 Nov 2023
  • Year ended 31 Dec 2021filed on 30 Sep 2022

DR. DE PAUW, Algemene Geneeskunde's financial analysis

Management and control of DR. DE PAUW, Algemene Geneeskunde

2 active director(s) in the register.

DR. DE PAUW, Algemene Geneeskunde's shareholders and holdings →

DR. DE PAUW, Algemene Geneeskunde's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0882.029.116
VAT number
BE0882029116
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
23 Jun 2006
Registered office
9320 Aalst
Size
Micro · 1.7 FTE
Latest accounts
2025 · filed on 23 Sep 2026
Activity
General medical practice activities (NACE 86210)

DR. DE PAUW, Algemene Geneeskunde (SRL) has been based in Aalst since 2006, active in: general medical practice activities. For 2025, it reports a net profit of 114,491 € and equity of 415,981 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 22.4%, below the median of its sector (72.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to DR. DE PAUW, Algemene Geneeskunde

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about DR. DE PAUW, Algemene Geneeskunde

What is the revenue of DR. DE PAUW, Algemene Geneeskunde?

DR. DE PAUW, Algemene Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of DR. DE PAUW, Algemene Geneeskunde?

In Belgium, the VAT number is the company number prefixed with BE: BE0882029116 for DR. DE PAUW, Algemene Geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0882.029.116.

Where is the registered office of DR. DE PAUW, Algemene Geneeskunde?

According to the CBE register, the registered office of DR. DE PAUW, Algemene Geneeskunde is in 9320 Aalst.

What is the equity of DR. DE PAUW, Algemene Geneeskunde?

At the close of the 2025 financial year, the equity of DR. DE PAUW, Algemene Geneeskunde amounts to 415,981 €, a solvency of 22.4% of total assets.

How many people work at DR. DE PAUW, Algemene Geneeskunde?

1.7 full-time equivalents on average according to the 2025 social balance sheet.

Who manages DR. DE PAUW, Algemene Geneeskunde?

The register lists 2 active mandates at DR. DE PAUW, Algemene Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is DR. DE PAUW, Algemene Geneeskunde within its sector?

By total assets for 2025, DR. DE PAUW, Algemene Geneeskunde ranks among the 500 largest of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.

Idonis

The full file of DR. DE PAUW, Algemene Geneeskunde

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 03 Oct 2026

No credit card, no commitment.

What each plan unlocks →